Gubra
374.40 DKK
+1.57 %
Less than 1K followers
GUBRA
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Gubra
P/E
Median 2023-2025
EV/S
Median 2023-2024
Dividend yield
Median 2023-2025
P/B
Median 2023-2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share price (DKK) | - | 125.00 | 624.00 | 517.50 |
| Shares | 0.1 | 16.3 | 16.3 | 16.3 |
| Market cap | - | 2,043.7 | 10,202.2 | 8,452.3 |
| Enterprise value | - | 2,061.8 | 10,164.3 | - |
| EV/S | - | 10.1 | 38.2 | - |
| EV/EBITDA | - | neg. | neg. | - |
| EV/EBIT | - | neg. | neg. | - |
| P/E | - | neg. | neg. | 5.0 |
| P/B | - | 4.26 | 22.64 | 7.38 |
| P/S | - | 10.0 | 38.4 | 3.2 |
| Dividend yield | - | 0.0 % | 9.8 % | 0.0 % |
| Equity ratio | 41.2 % | 76.7 % | 73.6 % | 86.8 % |
| Gearing ratio | 64.1 % | 14.9 % | 21.4 % | 9.4 % |